Paid Clinical Trials in Fayetteville, NC
As of August 2026, 46 paid clinical trials are recruiting in Fayetteville, North Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fayetteville offers studies at sites including Cross Creek Medical Clinic for conditions such as Crohn's Disease, Breast Cancer, Ulcerative Colitis, Chronic Weight Management. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Fayetteville
Trials by drug in Fayetteville
Filter results
Newly added in Fayetteville
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
43 clinical trials
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Confirmatory Clinical Study in Active Ulcerative Colitis
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Integrated Cancer Repository for Cancer Research
ERP to Improve Functioning in Veterans With OCD
Exercise Reset for Concussion in a Military Environment
Scheduled or As Needed Pain Regimen?
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
Top Research Study Locations in Fayetteville
Researchers run research studies in Fayetteville, NC at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cross Creek Medical Clinic | Colitis, Ulcerative, Crohn's Disease, Inflammatory Bowel Diseases | 7 |
| Coastal Research Institute, LLC | Chronic Idiopathic Constipation (CIC), HOMA-IR, Liver Fibrosis | 4 |
| Cape Fear Valley Medical Center | Breast Cancer, Pain, Postoperative, Type 2 Diabetes | 3 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease, Irritable Bowel Syndrome, Metabolic Dysfunction-Associated Steatohepatitis | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Coastal Research Institute | MASH - Metabolic Dysfunction-Associated Steatohepatitis, Metabolic Dysfunction-associated Steatohepatitis | 2 |
| Coastal Research Institute - Fayetteville | Obesity or Overweight, Crohn's Disease, Ulcerative Colitis | 2 |
| Cape Fear Valley Health System | Anal Cancer, Bile Duct Cancer, Bladder Cancer | 2 |
| ACCOMPLISH-1 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Cape Fear Valley Cancer Center | Extensive-stage Small Cell Lung Cancer (ES-SCLC), Small Cell Lung Cancer (SCLC) | 1 |
| Cape Fear Valley Health System (Javara Inc.) | Diabetes Mellitus, Type 2, Metabolic Syndrome, PreDiabetes | 1 |
| Cape Fear Valley Health Systems - Cancer Center | Breast Cancer | 1 |
| Care Access - Fayetteville | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| Cinical Study Site | Myasthenia Gravis, Generalized | 1 |
| Cross Creek Medical Clinic, PA | Systemic Lupus Erythematosus | 1 |
| Fayetteville VA Medical Center, Fayetteville, NC | Comorbid Post-Traumatic Stress Disorder and OCD, Obsessive Compulsive Disorder (OCD) | 1 |
| Fort Bragg | Cognitive Performance, PTSD | 1 |
| Fort Liberty | Brain Concussion | 1 |
| Ft. Bragg | Military Activity, Military Operations | 1 |
| Javara Inc. | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 1 |
| Vima | Dystonia | 1 |
| WR-Carolina Institute for Clinical Research | Atrophic Vaginitis, Genitourinary Syndrome of Menopause, Lichen Planus of Vulva | 1 |
Active & Upcoming Studies in Fayetteville (2026)
Recruiting trials in Fayetteville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (13 active studies)
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Cancer & tumors (5 active studies)
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy · Phase 3 · Boehringer Ingelheim
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence · Phase 3 · Stemline Therapeutics, Inc.
Cardiovascular (2 active studies)
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin · Phase 3 · AstraZeneca
Mental health & behavior (1 active study)
Neurology & pain (1 active study)
- Scheduled or As Needed Pain Regimen? · Phase 4 · Cape Fear Valley Health System
Common conditions studied in Fayetteville
- Crohn's Disease (4 active studies)
- Breast Cancer (3 active studies)
- Ulcerative Colitis (3 active studies)
- Chronic Weight Management (2 active studies)
- MASH - Metabolic Dysfunction-Associated Steatohepatitis (2 active studies)
- Non-alcoholic Fatty Liver Disease (2 active studies)
Leading research sponsors in Fayetteville
- Boehringer Ingelheim
- Sanofi
- Eli Lilly and Company
- GlaxoSmithKline
- 89bio, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Fayetteville?
There are approximately 46 recruiting clinical trials in Fayetteville, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fayetteville pay participants?
Most recruiting trials in Fayetteville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fayetteville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fayetteville?
The most common conditions under active study in Fayetteville include Crohn's Disease (4), Breast Cancer (3), Ulcerative Colitis (3), Chronic Weight Management (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fayetteville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fayetteville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fayetteville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fayetteville?
Recruiting research sites in Fayetteville include Cross Creek Medical Clinic, Coastal Research Institute, LLC, Cape Fear Valley Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fayetteville right now?
The largest active categories in Fayetteville are Diabetes & metabolic (13), Cancer & tumors (5), Cardiovascular (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.